They have always maintained a 12 month trial duration, from inception last year. It has added a quarter, as trials do - but otherwise nothing to suggest an early finish.
There is one one US trial site date supporting an early finish against no enrolment completion announcement for btx1503, presentation timelines, aus site update and previous guidance.
The mention of the enrolment of 1/2 patients halfway into the trial is more to take clinical site updates with a grain of salt, as we know they have done more than that (pg19 some au sites reaching max numbers early q1). As mentioned, the US site has not updated the estimated finish dates since the study was registered. Yes, I am a bit sad for watching the recruitment/clinical sites , with little else to do while waiting.
Ann: Investor Presentation, page-134
-
- There are more pages in this discussion • 17 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
32.0¢ |
Change
0.005(1.59%) |
Mkt cap ! $707.4M | |||
| Open | High | Low | Value | Volume |
| 31.5¢ | 32.5¢ | 31.0¢ | $1.169M | 3.655M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 9 | 274982 | 31.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 32.0¢ | 48600 | 2 |
View Market Depth
| Last trade - 16.10pm 22/11/2024 (20 minute delay) ? |
| BOT (ASX) Chart |
